First Neuropharmacological Contribution

Congratulations to Ali and Mariann for the first neuropharmacological contribution from our laboratory with the article A computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque . This study first surveys all 14 different tasks that have ever been used with Guanfacine in nonhuman primate studies and than shows in a single case study how rigorous computational reinforcement learning modelling extends existing knowledge by informing about the fundamental learning mechanisms that this drug affects during complex reversal learning. This article is particular important as it paves the way for a more formal computational approach to understand the neural effects of systemically acting psychoactive drugs like Guanfacine (which is uses in Attention Deficit Hyperactivity Disorder, mild cognitive impairment, and more). Congrats Ali and Mariann and all co-authors that made this study possible!

Related News

Inter-areal neural routing states emerge and switch during oscillatory bursts and with attention

We have a new major finding published at Neuron. We found that spiking in different areas (ACC, Striatum, LPFC) engage in ~20ms wide correlations, and that this coordinated activity has systematic time lags that correspond to the anatomical connectivity. These ‘baseline routing states’ are amplified during beta bursts, and switch directionality (between ACC and PFC) […]

Acetylcholine, Dopamine, and Glutamate measured in three brain areas with a new SPME-probe

Our new paper shows reliable Multi-Neuromodulator measurements in the awake nonhuman primate in prefrontal cortex, premotor cortex and the basal ganglia using a new chemical sensing probe. The probe uses principles of Solid-Phase-Microextraction and is a development by the SPME pioneer and collaborator Prof. Janusz Pawliszyn from the University of Waterloo. The paper can be […]

Acetylcholinergic Drug enhances attention at different dose as cognitive flexibility

Acetylcholinergic Drug enhances attention at different dose as cognitive flexibilityWe tested how a cholinergic drug that is used to treat symptoms of dementia (donepezil, Arizept) affects cognitive abilities across multiple domains in monkeys. We found that donepezil showed stunning improvements of attentional filtering (less distraction) during visual search but at a different dose at it […]